These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 21190368)
1. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids. Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368 [TBL] [Abstract][Full Text] [Related]
2. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643 [TBL] [Abstract][Full Text] [Related]
3. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22. Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725 [TBL] [Abstract][Full Text] [Related]
4. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases. Du J; Qiao Y; Sun L; Wang X Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455 [TBL] [Abstract][Full Text] [Related]
5. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity. Walton ZE; Bishop AC Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861 [TBL] [Abstract][Full Text] [Related]
6. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening. Hou X; Li R; Li K; Yu X; Sun JP; Fang H J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368 [TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Vang T; Miletic AV; Bottini N; Mustelin T Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. Stanford SM; Krishnamurthy D; Falk MD; Messina R; Debnath B; Li S; Liu T; Kazemi R; Dahl R; He Y; Yu X; Chan AC; Zhang ZY; Barrios AM; Woods VL; Neamati N; Bottini N J Med Chem; 2011 Mar; 54(6):1640-54. PubMed ID: 21341673 [TBL] [Abstract][Full Text] [Related]
9. A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors. Suryanarayanan V; Singh SK; Tripathi SK; Selvaraj C; Reddy KK; Karthiga A SAR QSAR Environ Res; 2013; 24(12):1025-40. PubMed ID: 23987088 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors. Liang X; Fu H; Xiao P; Fang H; Hou X Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612 [TBL] [Abstract][Full Text] [Related]
12. In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation. Wu S; Bottini M; Rickert RC; Mustelin T; Tautz L ChemMedChem; 2009 Mar; 4(3):440-4. PubMed ID: 19177473 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W. Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725 [TBL] [Abstract][Full Text] [Related]
14. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes. Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437 [TBL] [Abstract][Full Text] [Related]
15. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Gianchecchi E; Palombi M; Fierabracci A Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816 [TBL] [Abstract][Full Text] [Related]
16. Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy. Liang X; Zhao H; Du J; Li X; Li K; Zhao Z; Bi W; Zhang X; Yu D; Zhang J; Fang H; Hou X Eur J Med Chem; 2023 Oct; 258():115599. PubMed ID: 37399712 [TBL] [Abstract][Full Text] [Related]
18. Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype. Vidović D; Xie Y; Rinderspacher A; Deng SX; Landry DW; Chung C; Smith DH; Tautz L; Schürer SC J Comput Aided Mol Des; 2011 Sep; 25(9):873-83. PubMed ID: 21904909 [TBL] [Abstract][Full Text] [Related]